The system presents two aptamer-based assays, one for GA with a dynamic range of 3–20 mg/ml, another for serum albumin with a range of 20–50 ml/ml, and successfully integrates both into a dual assay cartridge and hence demonstrating potential as an effective platform for tracking GDM at the POC. This evidence concerns the gene ALB and gestational diabetes.